slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,557
Current window 42,331-42,360
Pages 2,019
Rows per page 30
Component
42,331-42,360 of 60,557
56
Highlights NXC-201's lower fludarabine dose and Carvykti's longer infusion window.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
14
Kering | Investor Presentation Deck | 55 slidesKering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Rising Success1 hit
19
Includes commentary on EBIT margin dilution and CAPEX phasing.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · The BreakthroughLoop · Maturity Curve1 hit
22
Kering | Investor Presentation Deck | 55 slidesKering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · The BreakthroughLoop · Maturity Curve1 hit
25
Kering | Investor Presentation Deck | 55 slidesKering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
28
Includes a fashion photograph as a visual element.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
30
The waterfall chart shows the bridge from H1 2022 to H1 2023 revenue for Kering Eyewear.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
31
The table presents a standard income statement comparison between two half-year periods.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
32
The table highlights the impact of real estate acquisitions on free cash flow.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
38
EP&L stands for Environmental Profit & Loss. The slide uses a bubble matrix to show impact distribution and a line chart to show intensity reduction over time.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
46
Includes two donut charts representing store counts and revenue share, and a table detailing quarterly performance by geography.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
47
Includes two donut charts showing store count and revenue breakdown, plus a table of quarterly performance metrics.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
50
Kering | Investor Presentation Deck | 55 slidesKering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
51
The table shows a flat performance for the total group (0% change) despite varying performance across individual houses.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
52
The table is split into two sections: financial results and income tax metrics.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
53
Values in millions of Euros (€M).Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
03
Note at bottom: Lakeland's fiscal year end is January 31Lakeland Bancorp | Results Presentation Deck | 14 slides · Lakeland
Conference presentation Investor relations Beat · Setup1 hit
05
Lakeland Bancorp | Results Presentation Deck | 14 slidesLakeland Bancorp | Results Presentation Deck | 14 slides · Lakeland
Conference presentation Investor relations Beat · KPI Overview1 hit
09
Includes a footnote regarding the acquisition closing date.Lakeland Bancorp | Results Presentation Deck | 14 slides · Lakeland
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
12
The table shows growth across all key metrics including Net Sales, Gross Margin, Adjusted EBITDA, and EPS.Lakeland Bancorp | Results Presentation Deck | 14 slides · Lakeland
Conference presentation Investor relations 1 hit
13
The table provides a transparent breakdown of non-GAAP adjustments including equity compensation, revaluation of earnout consideration, and facility start-up costs.Lakeland Bancorp | Results Presentation Deck | 14 slides · Lakeland
Conference presentation Investor relations 1 hit
14
Lakeland Bancorp | Results Presentation Deck | 14 slidesLakeland Bancorp | Results Presentation Deck | 14 slides · Lakeland
Conference presentation Investor relations 1 hit
12
The slide uses a table to establish clinical credibility for the MM-120 program by citing historical and contemporary research.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
19
The slide outlines a clinical trial design (MMED007) using a timeline-based visualization.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
03
Neumora Therapeutics | IPO Presentation Deck | 32 slidesNeumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank Beat · Setup1 hit
09
The slide uses a comparative structure to justify the strategic shift in trial design post-acquisition.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank Beat · ComplicationLoop · Cost Of Inaction1 hit
11
The table displays statistical significance (p-values) for multiple clinical endpoints.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank Beat · EvidenceLoop · Jobs To Be Done1 hit
12
TEAE = Treatment-Emergent Adverse Events. Data compares Navacaprant vs Placebo (n=102 each).Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank Beat · EvidenceLoop · Jobs To Be Done1 hit
13
Includes a timeline diagram for the randomized, double-blind treatment phase and a summary table of inclusion criteria and endpoints.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
14
The table uses a color-coded legend for 'Degree of preference' (High, Medium, Low).Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit